Alerts will be sent to your verified email
Verify Email
KABRADG
|
Kabra Drugs
|
Asston Pharma
|
Godavari Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
21.53 % | 31.69 % | 14.06 % |
|
5yr average Equity Multiplier
|
-0.87 | 5.73 | 3.51 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.79 | 1.24 |
|
5yr Avg Net Profit Margin
|
0.0 | 10.83 % | 3.28 % |
|
Price to Book
|
2.62 | 6.72 | 1.43 |
|
P/E
|
56.91 | 16.53 | 17.54 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 121.8 Days | 107.21 Days |
|
Inventory Days
|
0.0 | 31.3 Days | 47.15 Days |
|
Days Receivable
|
0.0 | 296.65 Days | 163.82 Days |
|
Days Payable
|
0.0 | 343.23 Days | 106.32 Days |
|
5yr Average Interest Coverage Ratio
|
-1068.45 | 3.57 | 2.61 |
|
5yr Avg ROCE
|
21.53 % | 42.37 % | 20.07 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 15.11 % | 8.03 % |
|
5 yr average Debt to Equity
|
-1.45 | 1.99 | 1.34 |
|
5yr CAGR Net Profit
|
43.36 % | 108.46 % | 1.18 % |
|
5yr Average Return on Assets
|
-21.34 % | 7.75 % | 4.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 50.66 % | 52.61 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.22 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.51 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kabra Drugs
|
Asston Pharma
|
Godavari Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|